Literature DB >> 35665908

Comment on: "Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?"

Mafalda Pestana1, Margarida Brito Caldeira2, Joana Cabete2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35665908     DOI： 10.1007/s40257-022-00694-z

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN： 1175-0561            Impact factor:   6.233


× No keyword cloud information.
  9 in total

Review 1.  Management of patients with hidradenitis suppurativa.

Authors:  A Martorell; A Caballero; Y González Lama; D Jiménez-Gallo; M Lázaro Serrano; J Miranda; J C Pascual; L Salgado-Boquete; I Marín-Jiménez
Journal:  Actas Dermosifiliogr       Date:  2016-09

2.  Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.

Authors:  Nikolas Plevris; Philip W Jenkinson; Ian D Arnott; Gareth R Jones; Charlie W Lees
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-01       Impact factor: 2.566

Review 3.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

4.  High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa.

Authors:  Mondana H Ghias; Andrew D Johnston; Allison J Kutner; Robert G Micheletti; H Dean Hosgood; Steven R Cohen
Journal:  J Am Acad Dermatol       Date:  2019-10-04       Impact factor: 11.527

5.  Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Authors:  Wei-Ti Chen; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2019-09-01       Impact factor: 10.282

6.  Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

Authors:  Tasnim Abdalla; Michelle A Lowes; Nirmal Kaur; Robert G Micheletti; A Hillary Steinhart; Afsaneh Alavi
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 6.233

7.  Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario.

Authors:  Francesco Giudici; Laura Maggi; Raffaella Santi; Lorenzo Cosmi; Francesco Annunziato; Gabriella Nesi; Giusi Barra; Gabrio Bassotti; Raffaele De Palma; Francesco Tonelli
Journal:  Clin Mol Allergy       Date:  2015-07-22

Review 8.  Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease.

Authors:  Deirdre Nathalie Dufour; Lennart Emtestam; Gregor B Jemec
Journal:  Postgrad Med J       Date:  2014-02-24       Impact factor: 2.401

9.  HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.

Authors:  A B Kimball; J M Sobell; C C Zouboulis; Y Gu; D A Williams; M Sundaram; H D Teixeira; G B E Jemec
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-07-22       Impact factor: 6.166
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.